Biotechnology company Atelerix has launched Storganoid, an ambient-temperature preservation solution for organoids and spheroids.
Storganoid enables the storage and shipment of complex 3D cell models over extended periods of time while preserving viability and reproducibility.
“Storganoid addresses one of the key barriers to broader adoption of these highly predictive cell-based models by freeing them from the constraints of specialised laboratory environments and lengthy culture protocols,” said Atelerix cofounder and CSO Steve Swioklo.
Organoids and spheroids are complex, fragile and highly sensitive to temperature fluctuations. Conventional cryopreservation and hypothermic approaches can alter their structural and functional integrity, limiting their use in specialist laboratories and restricting broader adoption.
Using its hydrogel technology, Atelerix has developed Storganoid to enable organoids and spheroids to be stored in assay-ready format at ambient temperatures, eliminating the need for complex and lengthy culture procedures.
Encapsulation within a soft hydrogel matrix stabilises cell membrane integrity, removing the need for cold chain logistics and complex handling procedures. This method supports the transfer of complex models between global sites and facilitates wider use in research and drug development and disease modelling.
